Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Weight and weight change and risk of atrial fibrillation: the HUNT study.

Feng T, Vegard M, Strand LB, Laugsand LE, Mørkedal B, Aune D, Vatten L, Ellekjær H, Loennechen JP, Mukamal K, Janszky I.

Eur Heart J. 2019 Jun 17. pii: ehz390. doi: 10.1093/eurheartj/ehz390. [Epub ahead of print]

PMID:
31209455
2.

Random error units, extension of a novel method to express random error in epidemiological studies.

Janszky I, Bjørngaard JH, Romundstad P, Vatten L, Orsini N.

Clin Epidemiol. 2019 Jan 23;11:127-132. doi: 10.2147/CLEP.S184231. eCollection 2019.

3.

Metabolically Healthy Obesity and Risk for Atrial Fibrillation: The HUNT Study.

Feng T, Vegard M, Strand LB, Laugsand LE, Mørkedal B, Aune D, Vatten L, Ellekjaer H, Loennechen JP, Mukamal K, Janszky I.

Obesity (Silver Spring). 2019 Feb;27(2):332-338. doi: 10.1002/oby.22377. Epub 2019 Jan 3.

PMID:
30605242
4.

Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.

Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kitahara CM, Larsson SC, Linet M, Merritt MA, Milne RL, Pala V, Palmer JR, Peeters PH, Riboli E, Sund M, Tamimi RM, Tjønneland A, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Wolk A, Zheng W, Weinberg CR, Swerdlow AJ, Sandler DP.

Ann Intern Med. 2019 Jan 1;170(1):22-30. doi: 10.7326/M18-1323. Epub 2018 Dec 11.

PMID:
30534999
5.

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.

Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, Ozasa K, Platz EA, Quirós JR, Rissanen H, Sawada N, Stampfer M, Stanczyk FZ, Stattin P, Tamakoshi A, Tangen CM, Thompson IM, Tsilidis KK, Tsugane S, Ursin G, Vatten L, Weiss NS, Yeap BB, Allen NE, Key TJ, Travis RC.

Eur Urol. 2018 Nov;74(5):585-594. doi: 10.1016/j.eururo.2018.07.024. Epub 2018 Aug 1.

6.

Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.

Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ.

JAMA Oncol. 2018 Nov 1;4(11):e181771. doi: 10.1001/jamaoncol.2018.1771. Epub 2018 Nov 8.

7.

Chronic pain: One year prevalence and associated characteristics (the HUNT pain study).

Landmark T, Romundstad P, Dale O, Borchgrevink PC, Vatten L, Kaasa S.

Scand J Pain. 2013 Oct 1;4(4):182-187. doi: 10.1016/j.sjpain.2013.07.022.

PMID:
29913652
8.

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men.

Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, Cirillo PM, Cohn BA, Cook MB, Donovan JL, Ferrucci L, Garland CF, Giles GG, Goodman PJ, Habel LA, Haiman CA, Holly JMP, Hoover RN, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luostarinen T, MacInnis RJ, Mäenpää HO, Männistö S, Metter EJ, Milne RL, Nomura AMY, Oliver SE, Parsons JK, Peeters PH, Platz EA, Riboli E, Ricceri F, Rinaldi S, Rissanen H, Sawada N, Schaefer CA, Schenk JM, Stanczyk FZ, Stampfer M, Stattin P, Stenman UH, Tjønneland A, Trichopoulou A, Thompson IM, Tsugane S, Vatten L, Whittemore AS, Ziegler RG, Allen NE, Key TJ, Travis RC.

PLoS One. 2017 Dec 27;12(12):e0187741. doi: 10.1371/journal.pone.0187741. eCollection 2017.

9.

APOBEC3A/B deletion polymorphism and cancer risk.

Gansmo LB, Romundstad P, Hveem K, Vatten L, Nik-Zainal S, Lønning PE, Knappskog S.

Carcinogenesis. 2018 Feb 9;39(2):118-124. doi: 10.1093/carcin/bgx131.

10.

The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.

Nichols HB, Schoemaker MJ, Wright LB, McGowan C, Brook MN, McClain KM, Jones ME, Adami HO, Agnoli C, Baglietto L, Bernstein L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Butler L, Chen Y, Doody MM, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Lund E, Ma H, Merritt MA, Milne RL, Navarro C, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Sandler DP, Swerdlow AJ.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1360-1369. doi: 10.1158/1055-9965.EPI-17-0246. Epub 2017 Jun 9. Review.

11.

Overweight, obesity and height as risk factors for meningioma, glioma, pituitary adenoma and nerve sheath tumor: a large population-based prospective cohort study.

Wiedmann MKH, Brunborg C, Di Ieva A, Lindemann K, Johannesen TB, Vatten L, Helseth E, Zwart JA.

Acta Oncol. 2017 Oct;56(10):1302-1309. doi: 10.1080/0284186X.2017.1330554. Epub 2017 May 26.

PMID:
28548875
12.

Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI.

Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a. No abstract available.

PMID:
28358128
13.

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk.

Gansmo LB, Bjørnslett M, Halle MK, Salvesen HB, Romundstad P, Hveem K, Vatten L, Dørum A, Lønning PE, Knappskog S.

BMC Cancer. 2017 Feb 3;17(1):97. doi: 10.1186/s12885-017-3094-y.

14.

The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study.

Wiedmann MKH, Brunborg C, Di Ieva A, Lindemann K, Johannesen TB, Vatten L, Helseth E, Zwart JA.

Neuro Oncol. 2017 Jul 1;19(7):976-985. doi: 10.1093/neuonc/now272. Erratum in: Neuro Oncol. 2017 Jun 1;19(6):877.

15.

Prevalence of the CHEK2 R95* germline mutation.

Knappskog S, Leirvaag B, Gansmo LB, Romundstad P, Hveem K, Vatten L, Lønning PE.

Hered Cancer Clin Pract. 2016 Sep 27;14:19. eCollection 2016.

16.

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer.

Helwa R, Gansmo LB, Romundstad P, Hveem K, Vatten L, Ryan BM, Harris CC, Lønning PE, Knappskog S.

Sci Rep. 2016 Sep 14;6:33153. doi: 10.1038/srep33153.

17.

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.

Gansmo LB, Vatten L, Romundstad P, Hveem K, Ryan BM, Harris CC, Knappskog S, Lønning PE.

Oncotarget. 2016 May 10;7(19):28637-46. doi: 10.18632/oncotarget.8705.

18.

Insomnia and left ventricular function - an echocardiography study.

Strand LB, Laugsand LE, Dalen H, Vatten L, Janszky I.

Scand Cardiovasc J. 2016 Jun;50(3):187-92. doi: 10.3109/14017431.2016.1157205. Epub 2016 May 10.

PMID:
26924518
19.

The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.

Gansmo LB, Bjørnslett M, Halle MK, Salvesen HB, Dørum A, Birkeland E, Hveem K, Romundstad P, Vatten L, Lønning PE, Knappskog S.

Tumour Biol. 2016 Aug;37(8):10697-702. doi: 10.1007/s13277-016-4940-2. Epub 2016 Feb 11.

20.

MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.

Gansmo LB, Romundstad P, Birkeland E, Hveem K, Vatten L, Knappskog S, Lønning PE.

Cancer Med. 2015 Dec;4(12):1901-7. doi: 10.1002/cam4.555. Epub 2015 Oct 16.

Supplemental Content

Loading ...
Support Center